- Home
- DFLI vs OSRH Comparison
DFLI vs OSRH Comparison
Compare DFLI & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DFLI | OSRH |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | United States |
| Employees | 141 | 22 |
| Industry | Electronic Components | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.2M | 17.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DFLI | OSRH |
|---|---|---|
| Price | $1.89 | $0.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.25 | N/A |
| AVG Volume (30 Days) | 380.6K | ★ 833.0K |
| Earning Date | 05-14-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.30 |
| Revenue Next Year | $51.17 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.15 | $0.32 |
| 52 Week High | $5.15 | $1.56 |
Technical Indicators
Market Signals| Indicator | DFLI | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 48.57 | 32.54 |
| Support Level | $1.89 | N/A |
| Resistance Level | $2.26 | $0.45 |
| Average True Range (ATR) | 0.14 | 0.03 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 56.86 | 14.90 |
Price Performance
Historical ComparisonAbout DFLI Dragonfly Energy Holdings Corp. (NV)
Dragonfly Energy Holdings Corp is engaged in the design, assembly, and sale of lithium-ion batteries, mainly lithium iron phosphate (LFP) batteries, for applications in recreational vehicles, marine, industrial, and other markets. The company operates through two segments: direct-to-consumer (DTC), which sells Battle Born branded batteries, and OEM, which supplies Dragonfly branded batteries to original equipment manufacturers.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.